2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Identification of Promising Targets for Tolerance Induction Following Heart Transplantation.

K. Klaeske, M.-T. Dieterlen, J. Fischer, J. Hahn, K. Jawad, J. Garbade, F. Mohr, S. Lehmann.
Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.

R. Hendrickson, M. Davis, A. Sherman, W. Andrews, J. Daniel, R. Fischer, D. Blowey.
Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis.

J. Gwiasda, H. Schrem, A. Kaltenborn.
Identifying Risk of Sepsis Early: A Way to Improve Outcomes for Patients with Early Allograft Dysfunction After Liver Transplantation?

D. Hoyer, T. Benko, G. Sotiropoulos, A. Paul, F. Saner.
Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .

I. Ushiro-Lumb,^1,2 M. Webster,¹ A. Kitchen.¹
Identifying the Specific Causes and the Determinants of Outcome in Kidney Recipients with Transplant Glomerulopathy: A Multicenter Study.

O. Aubert,¹ S. Higgins,¹ P. Campbell,² C. Loheac,¹ D. Viglietti,¹ D. Glotz,¹ C. Legendre,¹ C. Lefaucheur,¹ B. Sis,² J. Duong Van Huyen,¹ A. Loupy.¹
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).

B.-H. Shin,¹ S. Ge,¹ M. Chu,¹ J. Choi,¹ L. Winstedt,² C. Kjellman,² S. Louie,¹ A. Vo,¹ A. Peng,¹ S. Jordan,¹ M. Toyoda.¹
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-HLA Antibody (Ab), Resulting in Inhibition of Anti-HLA Ab-Mediated NK Cell Activation and Ab-Dependent Cell-Mediated Cytotoxicity (ADCC) in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts).

S. Ge, M. Chu, J. Choi, S. Louie, A. Kang, A. Vo, A. Peng, S. Jordan, M. Toyoda.
IgG Antibody Subclasses in Potential Renal Transplant Recipients with DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.

A. Contreras, A. Casillas, L. Llorente, G. Lima, A. Arvizu, A. De Santiago, M. Vilatoba, J. Alberu, J. Arreola-Guerra.
IgM Immunotherapy Restores Immune Homeostasis in Type 1 Diabetes.

P. Chhabra,¹ C. Wilson,² D. Moore,² K. Brayman.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z